Professor Caroline Dive has been named as part of the team to win Cancer Research UK’s Translational Cancer Research Prize for 2017.

The prize was awarded to the Tumour Heterogeneity Team, led by Professor Charles Swanton from The Francis Crick Institute, for its work to understand genomic complexity and heterogeneity in solid tumours, and to track tumour evolution through time and treatment. This programme of work includes the TRACERx Lung Study, the TRACERx Renal Study, PEACE (posthumous tissue donation in cancer) study, and a circulating tumour cell programme.

Professor Dive, who leads the Clinical and Experimental Pharmacology group at the Cancer Research UK Manchester Institute, works with Professor Swanton as part of the Cancer Research UK Lung Cancer Centre of Excellence.

This is not the first time that Caroline has won this award – in 2011 a Manchester team, jointly led by Professor Fiona Blackhall and comprising Professor Malcolm Ransom and Professor Andrew Hughes, was recognised for their biomarker research success. This work included the forerunner studies to this latest prize - demonstrating that circulating tumour cells in lung cancer can be used to predict response to treatment.